The 2nd most cited open-access journal in Endocrinology & Metabolism
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, Semantic Scholar, Ulrich's Periodicals Directory, Science Citation Index Expanded, CLOCKSS, EBSCO, OpenAIRE, Zetoc
PMCID: coming soon for all published articles
Diabetes welcomes submissions of the following article types: Case Report, Clinical Study Protocol, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Protocols, Review, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Diabetes, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Diabetes will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Neuroscience, Endocrinology, Public Health and Nutrition.